bpno.fi

Backlink analytics and domain authority

Backlinks
All Dofollow Nofollow UGC DR ▾ Ref. domains ▾
+ Add filter
50 backlinks All New Lost
Referring page DR Ref. domains Linked domains Anchor and target URL
EADV20: Biologics increase the risk of being infected with COVID-19
https://bpno.se/medtalks/eadv20-biologics-increase-the-risk-of-being-infected-with-covid-19
bpno.se
11 6 30
(no anchor)
https://bpno.fi/
DOFOLLOW
ASH20 Archives - BestPractice Nordic
https://bpno.se/tag/ash20
bpno.se
11 6 30
(no anchor)
https://bpno.fi/
DOFOLLOW
Slower cancer growth after venetoclax-rituximab treatment in patients with CLL
https://bpno.no/medtalks/slower-cancer-growth-after-venetoclax-rituximab-treatment-in-patients-with-cll
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
Robin Christensen, Author at BestPractice Nordic
https://bpno.no/author/robin-christensen
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
Does smoking really cause psoriasis?
https://bpno.se/medtalks/does-smoking-really-cause-psoriasis
bpno.se
11 6 30
(no anchor)
https://bpno.fi/
DOFOLLOW
Inger Pauline Landsem, Author at BestPractice Nordic
https://bpno.no/author/inger-pauline-landsem
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
UEGW24 Archives - BestPractice Nordic
https://bpno.se/tag/uegw24
bpno.se
11 6 30
(no anchor)
https://bpno.fi/
DOFOLLOW
ECTRIMS25 Archives - BestPractice Nordic
https://bpno.no/tag/ectrims25
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
News from EHA23 – A promising treatment option for follicular lymphoma
https://bpno.no/medtalks/news-from-eha23-a-promising-treatment-option-for-follicular-lymphoma
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
Belamaf and dexamethasone – Safe, effective multiple myeloma treatment
https://bpno.se/artiklar/belamaf-and-dexamethasone-safe-effective-multiple-myeloma-treatment
bpno.se
11 6 30
(no anchor)
https://bpno.fi/
DOFOLLOW
F-calprotectin associeret med mucosal inflammtorisk aktivitet ved colitis ulc...
https://bpno.no/medtalks/f-calprotectin-associeret-med-mucosal-inflammtorisk-aktivitet-ved-colitis-ulcerosa
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
New data for treatment of Papillary Renal Cell Carcinoma
https://bpno.no/medtalks/new-data-for-treatment-of-papillary-renal-cell-carcinoma
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
Cabozantinib significantly prolongs PFS compared to sunitinib in papillary RC...
https://bpno.no/artikler/cabozantinib-significantly-prolongs-pfs-compared-to-sunitinib-in-papillary-rcc
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
Lægemidler med virkning på IL-20 cytokin-familienGroup 3
https://bpno.dk/artikler/laegemidler-med-virkning-paa-il-20-cytokin-familien
bpno.dk
15 17 37
(no anchor)
https://bpno.fi/
DOFOLLOW
The microbiome and rodent models of immune mediated diseases - BestPractice N...
https://bpno.dk/medtalks/the-microbiome-and-rodent-models-of-immune-mediated-diseases
bpno.dk
15 17 37
(no anchor)
https://bpno.fi/
DOFOLLOW
Post-transplantasjons-diabetes hos organtransplanterte
https://bpno.no/artikler/post-transplantasjons-diabetes-hos-organtransplanterte
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
Hormone Replacement Therapy and Non-Hormonal Treatments for Menopause
https://bpno.no/medtalks/hormone-replacement-therapy-and-non-hormonal-treatments-for-menopause
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
Tubepapillom med BRAF (c.1799T>A)- mutasjon (V600E)
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
Nordic Breast Cancer Network Webinar 2025 - BestPractice Nordic
https://bpno.no/events/nordic-breast-cancer-network-webinar-2025
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
Atrieflimmer og risiko for hjerneslag hos pasienter med hypertrofisk kardiomy...
https://bpno.no/artikler/hva-vet-vi-om-atrieflimmer-og-risiko-for-hjerneslag-hos-pasienter-med-hypertrofisk-kardiomyopati
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
EADV 30th Congress - BestPractice Nordic
https://bpno.se/artiklar/eadv-30th-congress
bpno.se
11 6 30
(no anchor)
https://bpno.fi/
DOFOLLOW
Celeste Porsbjerg, Author at BestPractice Nordic
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
Tema om immunterapi - februar 2021 - BestPractice NordicGroup 3
https://bpno.dk/artikler/tema-om-immunterapi-februar-marts-april-2021
bpno.dk
15 17 37
(no anchor)
https://bpno.fi/
DOFOLLOW
Fatigue etter kreft
https://bpno.no/artikler/kronisk-fatigue-etter-kreft-i-ung-voksen-alder
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
Parkinson's Progress: Insights on Advanced Therapies
https://bpno.se/medtalks/parkinsons-progress-insights-on-advanced-therapies
bpno.se
11 6 30
(no anchor)
https://bpno.fi/
DOFOLLOW
Optimizing the front-line PARP-inhibitor treatment of ovarian cancer from a N...
https://bpno.no/medtalks/optimizing-the-front-line-parp-inhibitor-treatment-of-ovarian-cancer-from-a-nordic-perspective
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
ICML 2019, LUGANO NORDIC HIGHLIGHTS EVENING - BestPractice Nordic
https://bpno.no/events/icml-2019-lugano-nordic-highlights-evening
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
Mansoor Raza Mirza: ESMO is the Meeting Which Brings New Data for Forever Pra...
https://bpno.no/medtalks/mansoor-raza-mirza-esmo-is-the-meeting-which-brings-new-data-for-forever-practice-changing-trials
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
WCLC: Combining ipilimumab plus pembrolizumab did not add clinical benefit fo...
https://bpno.no/medtalks/wclc2021-combining-ipilimumab-plus-pembrolizumab-did-not-add-clinical-benefit-for-patients-nsclc
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
Risk of Mortality in Patients with Systemic Lupus Erythematosus
https://bpno.no/artikler/risk-of-mortality-in-patients-with-systemic-lupus-erythematosus
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
PRO - et kvalitetssikringsredskabGroup 3
https://bpno.dk/artikler/patient-reported-outcomes-pro-redskab-til-kvalitetssikring
bpno.dk
15 17 37
(no anchor)
https://bpno.fi/
DOFOLLOW
Nadja Skadkær Hansen, Author at BestPractice Nordic
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
Real-world Evidence on Lenvatinib plus Everolimus in Patients with Pre-treate...
https://bpno.se/medtalks/real-world-evidence-on-lenvatinib-plus-everolimus-in-patients-with-pre-treated-advanced-renal-cell-carcinoma
bpno.se
11 6 30
(no anchor)
https://bpno.fi/
DOFOLLOW
Skin cancer incidence and mortality – according to dermatologist density and ...
https://bpno.no/artikler/skin-cancer-incidence-and-mortality-according-to-dermatologist-density-and-population-risk-factors
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
There Is Definitely A Need for Novel Treatments for Elderly Patients with Man...
https://bpno.dk/medtalks/there-is-definitely-a-need-for-novel-treatments-for-elderly-patients-with-mantle-cell-lymphoma
bpno.dk
15 17 37
(no anchor)
https://bpno.fi/
DOFOLLOW
mikkel
https://bpno.dk/author/mikkel
bpno.dk
15 17 37
(no anchor)
https://bpno.fi/
DOFOLLOW
Resultaterne fra Solar-1 lover godt for alpelisib plus fulvestrant til patien...
https://bpno.no/artikler/resultaterne-fra-solar-1-lover-godt-for-alpelisib-plus-fulvestrant-til-patienter-med-hr-positiv-her2-negativ-avanceret-brystkraeft-med-pi3kca-mutationer
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
Treat to Target (T2T) - BestPractice No
https://bpno.no/medtalks/praktisk-handtering-av-ak-behandling
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
Meet the experts • Brystcancer - BestPractice NordicGroup 3
https://bpno.dk/publikationer/meet-the-experts-brystcancer-2022
bpno.dk
15 17 37
(no anchor)
https://bpno.fi/
DOFOLLOW
A new classification system for perianal fistulising Crohn's disease
https://bpno.no/medtalks/a-new-classification-system-for-perianal-fistulising-crohns-disease
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
Prophylactic Treatment Lowers Skin Toxicity in NSCLC Patients on Amivantamab ...
https://bpno.no/medtalks/prophylactic-treatment-lowers-skin-toxicity-in-nsclc-patients-on-amivantamab-lazertinib
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
Gene signature of drug response in AD predicts drug repurpose in asthma
https://bpno.no/medtalks/gene-signature-of-drug-response-in-ad-predicts-drug-repurpose-in-asthma
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
Borderline Ovarian Tumors Increase Risk of Some Non-Ovarian Cancers
https://bpno.no/artikler/borderline-ovarian-tumors-increase-risk-of-some-non-ovarian-cancers
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
The impact of the molecular profile and treatment of older and fragile patien...
https://bpno.no/medtalks/the-impact-of-the-molecular-profile-and-treatment-of-older-and-fragile-patients-with-relapsed-refractory-flt3-mutated-aml
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
The MCED blood test - A possible new era of early cancer detection
https://bpno.no/medtalks/the-mced-blood-test-a-possible-new-era-of-early-cancer-detection
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
Optimal Patient Population in the JAVELIN Bladder 100-trialGroup 3
https://bpno.dk/medtalks/optimal-patient-population-in-the-javelin-bladder-100-trial
bpno.dk
15 17 37
(no anchor)
https://bpno.fi/
DOFOLLOW
Therapeutic Strategies During Cenobamate Treatment Initiation
https://bpno.se/medtalks/therapeutic-strategies-during-cenobamate-treatment-initiation
bpno.se
11 6 30
(no anchor)
https://bpno.fi/
DOFOLLOW
Giver barndomstraumer forandringer i stressresponsen som voksne?
https://bpno.no/artikler/har-pasienter-som-rapporterer-barndomstraumer-forandringer-i-stressresponsen-som-voksne
bpno.no
11 6 113
(no anchor)
https://bpno.fi/
DOFOLLOW
Danish Study Reveals Doubling of Kidney Cancer Cases and a Growing Gender Gap
bpno.se
11 6 30
(no anchor)
https://bpno.fi/
DOFOLLOW
Greetings from AAD in New OrleansGroup 3
https://bpno.dk/artikler/greetings-from-aad-in-new-orleans
bpno.dk
15 17 37
(no anchor)
https://bpno.fi/
DOFOLLOW
Next page →
Frequently Asked Questions
How many backlinks does bpno.fi have?
The backlinks page for bpno.fi shows all individual inbound links discovered in our crawl of the web. Each backlink represents a hyperlink on another website that points to a page on bpno.fi. Use the filters to narrow results by dofollow/nofollow status, domain rating, or anchor text.
What is a backlink?
A backlink is a hyperlink on one website that points to a page on a different website. Backlinks are one of the most important ranking factors in search engine algorithms because they act as votes of confidence from other sites. The more high-quality backlinks a domain has, the more authority search engines assign to it.
Are the backlinks to bpno.fi dofollow or nofollow?
Backlinks to bpno.fi include both dofollow and nofollow links. Dofollow links pass link equity (ranking power) to the target site, while nofollow links include a rel="nofollow" attribute that tells search engines not to pass authority. Both types contribute to a natural backlink profile, but dofollow links carry more SEO weight. You can filter by link type using the rel filter above the table.
How often is backlink data updated?
Backlink data is updated monthly when our web crawler completes a new cycle. Our pipeline processes billions of web pages to discover new backlinks, track lost links, and update domain authority scores. The freshness of data depends on when our crawler last visited the referring pages.